Product logins

Find logins to all Clarivate products below.


Blog

Here you will find relevant articles and insight into all Clarivate related products and news.

Featured posts

How J&J navigated regulatory approval for a Drug to Watch How J&J navigated regulatory approval for a Drug to Watch
Blog December 17, 2024
How J&J navigated regulatory approval for a Drug to Watch
PBM GPO market share shifts as health plan enrollment continues to churn PBM GPO market share shifts as health plan enrollment continues to churn
Blog December 11, 2024
PBM GPO market share shifts as health plan enrollment continues to churn
Drug combinations: your questions answered Drug combinations: your questions answered
Blog November 19, 2024
Drug combinations: your questions answered
How the U.S. election could impact the healthcare industries How the U.S. election could impact the healthcare industries
Blog October 17, 2024
How the U.S. election could impact the healthcare industries
Increasing your likelihood of success in dealmaking discussions Increasing your likelihood of success in dealmaking discussions
Blog October 17, 2024
Increasing your likelihood of success in dealmaking discussions
Beyond animal testing: the rise of organs-on-chips technology Beyond animal testing: the rise of organs-on-chips technology
Blog October 7, 2024
Beyond animal testing: the rise of organs-on-chips technology
Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot? Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot?
Blog September 25, 2024
Aiming for ‘Magic Bullets’ in Medicine: Are We Shooting Ourselves in the Foot?
chevron_left
chevron_right
Navigating reimbursement and formulary listing discussions: Six tips for more effective objection handling in pharmaceutical market access Navigating reimbursement and formulary listing discussions: Six tips for more effective objection handling in pharmaceutical market access
Blog September 19, 2024
Navigating reimbursement and formulary listing discussions: Six tips for more effective objection handling in pharmaceutical market access
Biotech financing’s rebound: How high will it go? Biotech financing’s rebound: How high will it go?
Blog September 17, 2024
Biotech financing’s rebound: How high will it go?
Early diagnosis in Alzheimer’s disease: A first step towards better care Early diagnosis in Alzheimer’s disease: A first step towards better care
Blog September 11, 2024
Early diagnosis in Alzheimer’s disease: A first step towards better care
Pharma’s pain from the Inflation Reduction Act will be felt well beyond the first 10 brands facing price cuts Pharma’s pain from the Inflation Reduction Act will be felt well beyond the first 10 brands facing price cuts
Blog September 5, 2024
Pharma’s pain from the Inflation Reduction Act will be felt well beyond the first 10 brands facing price cuts
After loss of exclusivity, small-molecule generics bite quick and hard, while biologics remain resilient After loss of exclusivity, small-molecule generics bite quick and hard, while biologics remain resilient
Blog August 28, 2024
After loss of exclusivity, small-molecule generics bite quick and hard, while biologics remain resilient
Pulsed field ablation re-energizes the atrial fibrillation market Pulsed field ablation re-energizes the atrial fibrillation market
Blog August 27, 2024
Pulsed field ablation re-energizes the atrial fibrillation market
CMS enters drug price negotiation arena in sea change for industry CMS enters drug price negotiation arena in sea change for industry
Blog August 20, 2024
CMS enters drug price negotiation arena in sea change for industry
Beyond transparent pricing: decoding the strategies of major PBMs Beyond transparent pricing: decoding the strategies of major PBMs
Blog August 7, 2024
Beyond transparent pricing: decoding the strategies of major PBMs
  NODES
COMMUNITY 1
innovation 4
Note 1